Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 4, 2014
Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates
Todd G Kirchgessner, Richard Martin, Paul Sleph, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 10, 2018
Reversible, orally available ADP receptor (P2Y<sub>12</sub>) antagonists Part I: Hit to lead process
Imadul Islam, Shendong Yuan, Robert G Wei, et al.
Journal of Medicinal Chemistry
|
January 23, 2009
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)
Brenton Flatt, Richard Martin, Tie-Lin Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand
Patricia J Willy, Ian R Murray, Jing Qian, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 2, 2014
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ
Ellen Kick, Richard Martin, Yinong Xie, et al.
Journal of Medicinal Chemistry
|
May 31, 2002
Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups
Gary Phillips, William J Guilford, Brad O Buckman, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2011
Discovery of a new class of glucosylceramide synthase inhibitors
Elena Koltun, Steven Richards, Vicky Chan, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Design, synthesis, and biological activity of novel factor Xa inhibitors: 4-aryloxy substituents of 2,6-diphenoxypyridines
Howard P Ng, Brad O Buckman, Keith A Eagen, et al.
Journal of Medicinal Chemistry
|
April 14, 2012
Discovery and characterization of an inhibitor of glucosylceramide synthase
Steven Richards, Christopher J Larson, Elena S Koltun, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
Discovery of Highly Potent Liver X Receptor β Agonists
Ellen K Kick, Brett B Busch, Richard Martin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Pharmacology and Experimental Therapeutics
|
December 4, 2014
Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates
Todd G Kirchgessner, Richard Martin, Paul Sleph, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 10, 2018
Reversible, orally available ADP receptor (P2Y<sub>12</sub>) antagonists Part I: Hit to lead process
Imadul Islam, Shendong Yuan, Robert G Wei, et al.
Journal of Medicinal Chemistry
|
January 23, 2009
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)
Brenton Flatt, Richard Martin, Tie-Lin Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand
Patricia J Willy, Ian R Murray, Jing Qian, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 2, 2014
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ
Ellen Kick, Richard Martin, Yinong Xie, et al.
Journal of Medicinal Chemistry
|
May 31, 2002
Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups
Gary Phillips, William J Guilford, Brad O Buckman, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2011
Discovery of a new class of glucosylceramide synthase inhibitors
Elena Koltun, Steven Richards, Vicky Chan, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Design, synthesis, and biological activity of novel factor Xa inhibitors: 4-aryloxy substituents of 2,6-diphenoxypyridines
Howard P Ng, Brad O Buckman, Keith A Eagen, et al.
Journal of Medicinal Chemistry
|
April 14, 2012
Discovery and characterization of an inhibitor of glucosylceramide synthase
Steven Richards, Christopher J Larson, Elena S Koltun, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
Discovery of Highly Potent Liver X Receptor β Agonists
Ellen K Kick, Brett B Busch, Richard Martin, et al.
Page
of 3